Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
CancerTYPE ID test
Also known as: formerly Theros CancerTYPE ID
print preview
bookmark
share with colleague
General Information
Company
bioMerieux S.A.
Description
Molecular cancer classification assay based on expression of 92 genes
Molecular Target
Mechanism of Action
Diagnostic
Latest Stage of Development
Marketed
Indication
Cancer, Diagnostic
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy